Your browser doesn't support javascript.
loading
Outcomes after lung transplantation in recipients aged 70 years or older.
Olson, Michael T; Elnahas, Shaimaa; Biswas Roy, Sreeja; Razia, Deepika; Kang, Paul; Bremner, Ross M; Smith, Michael A; Arjuna, Ashwini; Walia, Rajat.
Afiliação
  • Olson MT; Norton Thoracic Institute, St. Joseph's Hospital and Medical Center, Phoenix, Arizona, USA.
  • Elnahas S; University of Arizona College of Medicine - Phoenix Campus, Phoenix, Arizona, USA.
  • Biswas Roy S; Norton Thoracic Institute, St. Joseph's Hospital and Medical Center, Phoenix, Arizona, USA.
  • Razia D; Norton Thoracic Institute, St. Joseph's Hospital and Medical Center, Phoenix, Arizona, USA.
  • Kang P; Norton Thoracic Institute, St. Joseph's Hospital and Medical Center, Phoenix, Arizona, USA.
  • Bremner RM; University of Arizona College of Public Health, Phoenix, Arizona, USA.
  • Smith MA; Norton Thoracic Institute, St. Joseph's Hospital and Medical Center, Phoenix, Arizona, USA.
  • Arjuna A; Norton Thoracic Institute, St. Joseph's Hospital and Medical Center, Phoenix, Arizona, USA.
  • Walia R; Norton Thoracic Institute, St. Joseph's Hospital and Medical Center, Phoenix, Arizona, USA.
Clin Transplant ; 36(1): e14505, 2022 01.
Article em En | MEDLINE | ID: mdl-34634161
ABSTRACT

BACKGROUND:

The proportion of lung transplant (LTx) recipients older than 70 years is increasing, thus we assessed long-term survival after LTx in this cohort relative to younger counterparts. PATIENTS AND

METHODS:

We retrospectively reviewed charts of patients who underwent LTx between 2012 and 2016 at our center and divided patients by age group A (<65 years), B (65-69 years), and C (≥70 years). Survival statistics were evaluated using the Kaplan-Meier method and Cox regression.

RESULTS:

The study included 375 LTx recipients 221 (58.9%) in group A, 109 (29.1%) in group B, and 45 (12.0%) in group C. Group C was mostly men (37/45 [82.2%]; P = 0.003) and had the highest mean serum creatinine at listing (P = 0.02). Survival at 1, 3, and 5 years after transplant in group A (93.2%, 70.1%, 58.8%) was significantly higher than group B (83.5%, 59.6%, 44.0%; P = 0.005, 0.028, 0.006, log-rank test) and was similar to group C (86.7%, 64.4%, 57.8%), although trended higher at 1 year (P = 0.139, 0.274, 0.489, log-rank test). Groups B and C had comparable survival at all time points.

CONCLUSIONS:

Although survival decreased after age 65, long-term survival was comparable between LTx recipients aged 65-69 years and recipients ≥70 years.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Pulmão Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limite: Aged / Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Pulmão Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limite: Aged / Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article